Industry: Biotechnology
Total Companies
741
Total Market Cap
1,211.23B
Total Revenue
136.16B
741 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | NVO | Novo Nordisk A/S | 310.58B | 0.40% | 1,102,493 | 21.66B |
| 2 | VRTX | Vertex Pharmaceuticals, Inc. | 82.51B | 0.13% | 1,288,678 | 8.70B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 79.55B | 0.07% | 320,305 | 13.71B |
| 4 | MRNA | Moderna, Inc. | 72.74B | -2.01% | 2,355,492 | 21.39B |
| 5 | BNTX | BioNTech SE | 34.86B | 0.79% | 404,668 | 20.18B |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 28.46B | -0.09% | 820,482 | 960.92M |
| 7 | BGNE | BeiGene Ltd. | 27.01B | -0.70% | 231,874 | 1.25B |
| 8 | SGEN | Seagen, Inc. | 26.12B | 0.70% | 869,706 | 1.86B |
| 9 | GMAB | Genmab A/S | 25.64B | 0.49% | 565,941 | 1.55B |
| 10 | BMRN | BioMarin Pharmaceutical Inc. | 21.79B | 0.25% | 1,217,219 | 2.01B |
| 11 | ARGX | Argenx SE | 21.10B | -0.31% | 260,095 | 31.04M |
| 12 | INCY | Incyte Corporation | 19.07B | -0.36% | 707,677 | 3.33B |
| 13 | RPRX | Royalty Pharma PLC | 17.16B | 0.49% | 1,016,225 | 2.25B |
| 14 | TECH | Bio-Techne Corp | 12.74B | 1.08% | 740,408 | 1.12B |
| 15 | UTHR | United Therapeutics Corporation | 11.84B | -1.72% | 217,997 | 1.86B |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 10.79B | -1.27% | 724,377 | 876.05M |
| 17 | JAZZ | Jazz Pharmaceuticals PLC | 9.80B | 0.61% | 366,076 | 3.58B |
| 18 | LEGN | Legend Biotech Corporation | 8.82B | -2.10% | 1,488,208 | 116.94M |
| 19 | ASND | Ascendis Pharma A/S | 6.99B | 0.80% | 153,978 | 36.06M |
| 20 | HALO | Halozyme Therapeutics, Inc. | 6.86B | -4.82% | 1,451,650 | 580.62M |
| 21 | KRTX | Karuna Therapeutics, Inc. | 6.77B | 0.41% | 289,923 | 42.32M |
| 22 | ROIV | Roivant Sciences Ltd. | 6.20B | 2.15% | 1,378,605 | 50.42M |
| 23 | APLS | Apellis Pharmaceuticals, Inc. | 5.84B | -0.02% | 960,011 | 113.05M |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 5.68B | 1.63% | 487,172 | 875.48M |
| 25 | EXEL | Exelixis, Inc. | 5.64B | -1.36% | 1,597,903 | 1.64B |
| 26 | RXDX | Prometheus Biosciences, Inc. | 5.40B | 1.44% | 221,514 | 7.19M |
| 27 | CERE | Cerevel Therapeutics Holdings, Inc. | 5.38B | 4.52% | 391,009 | - |
| 28 | MDGL | Madrigal Pharmaceuticals, Inc. | 5.17B | -3.71% | 202,300 | - |
| 29 | ALKS | Alkermes PLC | 4.77B | 1.82% | 905,423 | 1.13B |
| 30 | ZLAB | Zai Lab Limited | 4.39B | 0.92% | 461,513 | 196.61M |
| 31 | DNLI | Denali Therapeutics Inc. | 4.27B | 3.08% | 374,702 | 110.69M |
| 32 | CRSP | CRISPR Therapeutics AG | 4.13B | 4.58% | 808,900 | 14.09M |
| 33 | VIR | Vir Biotechnology, Inc. | 4.11B | 2.87% | 631,838 | 2.38B |
| 34 | CYTK | Cytokinetics, Inc. | 4.08B | -0.30% | 405,922 | 148.23M |
| 35 | DNA | Ginkgo Bioworks Holdings, Inc. | 3.84B | 10.86% | 20,469,423 | 527.92M |
| 36 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.83B | 0.99% | 427,156 | 243.23M |
| 37 | ABCM | Abcam PLC | 3.77B | -1.91% | 698,874 | 427.32M |
| 38 | MRVI | Maravai LifeSciences Holdings, Inc. | 3.70B | 4.39% | 899,961 | 906.73M |
| 39 | PCVX | Vaxcyte, Inc. | 3.65B | -1.54% | 346,422 | - |
| 40 | FOLD | Amicus Therapeutics, Inc. | 3.60B | -2.58% | 1,783,935 | 323.29M |
| 41 | NTLA | Intellia Therapeutics, Inc. | 3.59B | 7.77% | 967,293 | 51.40M |
| 42 | PTCT | PTC Therapeutics, Inc. | 3.38B | 0.57% | 588,300 | 696.62M |
| 43 | BEAM | Beam Therapeutics Inc. | 3.19B | 3.31% | 519,493 | 91.95M |
| 44 | ABCL | AbCellera Biologics Inc. | 3.08B | 2.28% | 1,183,337 | 603.21M |
| 45 | RARE | Ultragenyx Pharmaceutical Inc. | 3.07B | -0.95% | 449,661 | 343.37M |
| 46 | MRTX | Mirati Therapeutics, Inc. | 3.06B | 3.98% | 862,546 | 11.80M |
| 47 | AXSM | Axsome Therapeutics, Inc. | 3.05B | -1.72% | 692,970 | 25.67M |
| 48 | ISEE | IVERIC bio, Inc. | 3.04B | 3.71% | 2,221,950 | - |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 3.01B | -0.48% | 935,237 | 511.50M |
| 50 | PRTA | Prothena Corporation PLC | 2.95B | 2.27% | 314,033 | 5.15M |
| 51 | INSM | Insmed, Inc. | 2.94B | 1.07% | 2,287,529 | 242.18M |
| 52 | GLPG | Galapagos NV | 2.91B | -0.85% | 107,704 | - |
| 53 | IMCR | Immunocore Holdings plc | 2.91B | 0.03% | 92,615 | 118.92M |
| 54 | HRMY | Harmony Biosciences Holdings, Inc. | 2.88B | -0.51% | 384,137 | 400.76M |
| 55 | BPMC | Blueprint Medicines Corporation | 2.86B | 0.06% | 217,875 | 272.28M |
| 56 | RVNC | Revance Therapeutics, Inc. | 2.73B | -2.21% | 728,841 | 108.59M |
| 57 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.71B | 2.02% | 447,439 | 345.00K |
| 58 | RLAY | Relay Therapeutics, Inc. | 2.65B | 8.37% | 1,437,757 | 1.70M |
| 59 | MYOV | Myovant Sciences Ltd. | 2.61B | -0.07% | 535,588 | 379.11M |
| 60 | SAGE | Sage Therapeutics, Inc. | 2.58B | -3.56% | 427,701 | 6.46M |
| 61 | CORT | Corcept Therapeutics Incorporated | 2.50B | 1.39% | 270,345 | 397.62M |
| 62 | RVMD | Revolution Medicines, Inc. | 2.46B | -0.43% | 856,779 | 29.51M |
| 63 | PROK | ProKidney Corp. | 2.36B | 11.33% | 70,822 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 2.35B | -1.31% | 313,999 | 13.17M |
| 65 | VTYX | Ventyx Biosciences, Inc. | 2.35B | 9.11% | 2,498,974 | - |
| 66 | AKRO | Akero Therapeutics, Inc. | 2.30B | 3.36% | 519,337 | - |
| 67 | IMVT | Immunovant, Inc. | 2.29B | 0.68% | 448,772 | - |
| 68 | CLDX | Celldex Therapeutics, Inc. | 2.18B | 0.92% | 225,551 | 1.08M |
| 69 | KRYS | Krystal Biotech, Inc. | 2.17B | 0.29% | 97,870 | - |
| 70 | CVAC | CureVac N.V. | 2.17B | 1.24% | 735,848 | 105.38M |
| 71 | TGTX | TG Therapeutics, Inc. | 2.13B | 3.39% | 3,776,538 | 5.03M |
| 72 | FGEN | FibroGen, Inc. | 2.04B | -1.63% | 487,822 | 122.91M |
| 73 | KYMR | Kymera Therapeutics, Inc. | 2.02B | 3.86% | 549,278 | - |
| 74 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.97B | -1.86% | 1,780,525 | 238.44M |
| 75 | XNCR | Xencor, Inc. | 1.95B | 2.27% | 259,418 | 296.98M |
| 76 | SWTX | Springworks Therapeutics, Inc. | 1.92B | 2.46% | 502,885 | - |
| 77 | SNDX | Syndax Pharmaceuticals, Inc. | 1.92B | -0.67% | 535,447 | 126.58M |
| 78 | VCYT | Veracyte, Inc. | 1.87B | -0.12% | 620,726 | 283.58M |
| 79 | NUVL | Nuvalent, Inc. | 1.83B | -1.87% | 78,420 | - |
| 80 | RCKT | Rocket Pharmaceuticals, Inc. | 1.75B | -0.71% | 607,880 | - |
| 81 | PLRX | Pliant Therapeutics, Inc. | 1.70B | -3.83% | 953,806 | 9.72M |
| 82 | PRME | Prime Medicine, Inc. | 1.70B | 1.34% | 82,022 | - |
| 83 | VRNA | Verona Pharma PLC | 1.70B | -1.36% | 930,222 | - |
| 84 | ARVN | Arvinas, Inc. | 1.69B | 1.66% | 260,804 | 112.13M |
| 85 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 0.10% | 497,204 | 9.93M |
| 86 | RCUS | Arcus Biosciences, Inc. | 1.67B | 0.17% | 957,677 | 432.84M |
| 87 | RYTM | Rhythm Pharmaceuticals, Inc. | 1.64B | -4.56% | 408,512 | 16.67M |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 4.27% | 732,373 | 28.70M |
| 89 | CPRX | Catalyst Pharmaceuticals, Inc. | 1.62B | -2.94% | 2,285,218 | 191.76M |
| 90 | IBRX | ImmunityBio, Inc. | 1.60B | 1.39% | 1,023,819 | 557.00K |
| 91 | KROS | Keros Therapeutics, Inc. | 1.60B | 0.33% | 193,196 | 20.00M |
| 92 | RETA | Reata Pharmaceuticals, Inc. | 1.59B | 6.19% | 653,551 | 3.15M |
| 93 | KDNY | Chinook Therapeutics, Inc. | 1.59B | 0.24% | 342,275 | 56.85M |
| 94 | DAWN | Day One Biopharmaceuticals, Inc. | 1.58B | -0.42% | 263,007 | - |
| 95 | RNA | Avidity Biosciences, Inc. | 1.56B | 4.50% | 810,882 | 8.31M |
| 96 | ACLX | Arcellx, Inc. | 1.54B | 2.41% | 371,489 | - |
| 97 | DICE | DICE Therapeutics, Inc. | 1.54B | 1.57% | 269,240 | - |
| 98 | GERN | Geron Corporation | 1.50B | -0.89% | 3,319,193 | 1.53M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.46B | -3.38% | 255,241 | 1.88M |
| 100 | REPL | Replimune Group, Inc. | 1.43B | -0.92% | 299,320 | - |
| 101 | TVTX | Travere Therapeutics, Inc. | 1.40B | 0.23% | 962,647 | 213.40M |
| 102 | VERV | Verve Therapeutics, Inc. | 1.38B | 1.86% | 477,558 | 929.00K |
| 103 | MNKD | MannKind Corporation | 1.38B | -1.51% | 1,877,287 | 76.23M |
| 104 | BBIO | BridgeBio Pharma, Inc. | 1.36B | 2.94% | 975,126 | 88.66M |
| 105 | VCEL | Vericel Corporation | 1.35B | 2.44% | 168,527 | 159.26M |
| 106 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.34B | 2.48% | 182,678 | - |
| 107 | ADPT | Adaptive Biotechnologies Corporation | 1.34B | 1.63% | 715,548 | 168.04M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.33B | 1.74% | 2,842,370 | 129.00M |
| 109 | NAMS | NewAmsterdam Pharma Co N.V. | 1.33B | 20.06% | 134,881 | 98.42M |
| 110 | IOVA | Iovance Biotherapeutics, Inc. | 1.29B | 6.11% | 7,165,837 | - |
| 111 | BHVN | Biohaven Ltd. | 1.28B | 1.46% | 735,060 | - |
| 112 | CINC | CinCor Pharma, Inc. | 1.26B | 0.03% | 235,227 | - |
| 113 | MORF | Morphic Holding, Inc. | 1.23B | 3.21% | 148,795 | 74.23M |
| 114 | SAVA | Cassava Sciences, Inc. | 1.21B | 3.58% | 1,962,454 | - |
| 115 | LGND | Ligand Pharmaceuticals Inc. | 1.19B | 0.82% | 62,750 | 241.67M |
| 116 | EQRX | EQRx, Inc. | 1.19B | 3.85% | 1,548,872 | - |
| 117 | INBX | Inhibrx, Inc. | 1.18B | 1.27% | 230,274 | 4.77M |
| 118 | ALLO | Allogene Therapeutics, Inc. | 1.14B | 1.15% | 1,976,831 | 247.00K |
| 119 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.10B | 2.15% | 653,651 | 5.11M |
| 120 | ENTA | Enanta Pharmaceuticals, Inc. | 1.09B | 0.99% | 104,986 | 86.16M |
| 121 | IMGN | ImmunoGen, Inc. | 1.05B | 0.85% | 1,457,301 | 95.61M |
| 122 | CDMO | Avid Bioservices, Inc. | 1.02B | 2.44% | 416,649 | 134.18M |
| 123 | BLU | BELLUS Health Inc. | 1.02B | 0.25% | 294,322 | 9.09K |
| 124 | ARQT | Arcutis Biotherapeutics, Inc. | 1.01B | 2.86% | 584,168 | 725.00K |
| 125 | COGT | Cogent Biosciences, Inc. | 1.01B | -2.17% | 457,538 | - |
| 126 | RGNX | REGENXBIO Inc. | 1.00B | 0.57% | 295,183 | 480.03M |
| 127 | VALN | Valneva SE | 998.84M | 1.15% | 4,922 | - |
| 128 | QURE | uniQure N.V. | 994.35M | -0.70% | 380,095 | 61.43M |
| 129 | KNSA | Kiniksa Pharmaceuticals Ltd. | 972.75M | 1.60% | 159,085 | 177.04M |
| 130 | PHAR | Pharming Group N.V. | 971.73M | 2.86% | 1,512 | 221.48M |
| 131 | IGMS | IGM Biosciences, Inc. | 962.74M | 2.23% | 121,175 | 697.00K |
| 132 | NVAX | Novavax, Inc. | 959.70M | 2.82% | 6,373,311 | 1.85B |
| 133 | RAPT | Rapt Therapeutics, Inc. | 949.66M | 1.86% | 309,632 | 2.28M |
| 134 | KURA | Kura Oncology, Inc. | 931.61M | -2.64% | 1,132,128 | - |
| 135 | SANA | Sana Biotechnology, Inc. | 917.39M | 4.34% | 1,167,272 | - |
| 136 | JANX | Janux Therapeutics, Inc. | 916.59M | - | 30,456 | 7.38M |
| 137 | ALBO | Albireo Pharma, Inc. | 914.23M | 0.27% | 846,186 | 57.39M |
| 138 | PRTC | PureTech Health PLC | 906.61M | -2.87% | 2,443 | 17.39M |
| 139 | BTAI | BioXcel Therapeutics, Inc. | 887.21M | -1.09% | 192,911 | 137.00K |
| 140 | INVA | Innoviva, Inc. | 885.55M | 0.08% | 404,584 | 373.22M |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 880.10M | 0.80% | 268,905 | 52.29M |
| 142 | LYEL | Lyell Immunopharma, Inc. | 832.75M | 1.83% | 539,101 | 39.12M |
| 143 | BCYC | Bicycle Therapeutics PLC | 831.31M | 0.25% | 316,533 | 15.05M |
| 144 | EXAI | Exscientia plc | 824.51M | - | 88,081 | 28.55M |
| 145 | AVXL | Anavex Life Sciences Corp. | 823.28M | 0.38% | 615,844 | - |
| 146 | IDYA | IDEAYA Biosciences, Inc. | 812.16M | 2.06% | 198,762 | 49.87M |
| 147 | ADMA | ADMA Biologics Inc. | 810.71M | - | 1,518,835 | 130.48M |
| 148 | AGEN | Agenus Inc. | 801.66M | 7.79% | 4,688,891 | 89.90M |
| 149 | FULC | Fulcrum Therapeutics, Inc. | 793.65M | 2.39% | 483,128 | 10.72M |
| 150 | PNT | POINT Biopharma Global, Inc. | 779.66M | 2.22% | 475,645 | - |
| 151 | DYN | Dyne Therapeutics, Inc. | 770.96M | 4.30% | 192,265 | - |
| 152 | PRVB | Provention Bio, Inc. | 764.66M | 0.69% | 631,282 | 2.80M |
| 153 | ICPT | Intercept Pharmaceuticals, Inc. | 762.07M | 0.16% | 458,103 | 330.33M |
| 154 | ALEC | Alector, Inc. | 757.55M | 2.12% | 363,706 | 133.17M |
| 155 | ITOS | iTeos Therapeutics, Inc. | 751.35M | -5.08% | 324,006 | 454.23M |
| 156 | AMRN | Amarin Corporation Plc | 747.08M | 2.21% | 13,205,155 | 423.44M |
| 157 | BLTE | Belite Bio, Inc | 744.78M | -0.99% | 778 | - |
| 158 | TBPH | Theravance Biopharma, Inc. | 732.27M | 1.87% | 351,069 | 51.64M |
| 159 | CTIC | CTI BioPharma Corp. | 725.83M | -1.72% | 2,414,428 | 32.87M |
| 160 | EWTX | Edgewise Therapeutics, Inc. | 689.66M | 0.37% | 56,327 | - |
| 161 | MCRB | Seres Therapeutics, Inc. | 688.99M | 0.36% | 909,150 | 13.37M |
| 162 | FDMT | 4D Molecular Therapeutics, Inc. | 688.66M | 5.09% | 198,003 | 1.97M |
| 163 | ANAB | AnaptysBio, Inc. | 685.49M | -1.23% | 678,079 | 4.49M |
| 164 | MRUS | Merus N.V. | 682.97M | - | 272,676 | 45.63M |
| 165 | SMMT | Summit Therapeutics Inc. | 682.57M | -7.71% | 2,788,803 | 1.18M |
| 166 | MOR | MorphoSys AG | 675.02M | 0.20% | 71,449 | - |
| 167 | MRSN | Mersana Therapeutics, Inc. | 665.49M | 3.09% | 799,118 | 11.90M |
| 168 | PTGX | Protagonist Therapeutics, Inc. | 663.69M | 2.35% | 966,390 | 35.20M |
| 169 | CBAY | CymaBay Therapeutics Inc. | 660.51M | -3.23% | 1,325,582 | - |
| 170 | EDIT | Editas Medicine, Inc. | 658.06M | 5.51% | 1,274,903 | 25.64M |
| 171 | VKTX | Viking Therapeutics, Inc. | 657.22M | 2.02% | 898,433 | - |
| 172 | SRRK | Scholar Rock Holding Corporation | 654.06M | 1.12% | 155,784 | 37.24M |
| 173 | ALT | Altimmune, Inc. | 650.37M | -4.89% | 1,588,162 | 3.32M |
| 174 | CHRS | Coherus BioSciences, Inc. | 648.67M | -0.12% | 916,768 | 239.06M |
| 175 | BLUE | Bluebird Bio, Inc. | 646.36M | 0.80% | 2,669,681 | -35.75M |
| 176 | CARA | Cara Therapeutics, Inc. | 644.80M | -2.20% | 218,073 | 39.43M |
| 177 | PSTX | Poseida Therapeutics, Inc. | 631.73M | 0.41% | 268,019 | 151.68M |
| 178 | ALLK | Allakos Inc. | 627.95M | 2.79% | 488,378 | - |
| 179 | ERAS | Erasca, Inc. | 606.22M | 3.32% | 1,001,922 | - |
| 180 | IMTX | Immatics N.V. | 603.72M | 1.41% | 167,001 | 150.91M |
| 181 | ZYME | Zymeworks Inc. | 603.50M | -1.74% | 370,059 | 29.86M |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 592.63M | -1.25% | 278,350 | - |
| 183 | SGMO | Sangamo Therapeutics, Inc. | 586.69M | 3.77% | 882,832 | 112.06M |
| 184 | NRIX | Nurix Therapeutics, Inc. | 583.69M | 2.31% | 161,676 | 39.24M |
| 185 | AVTE | Aerovate Therapeutics, Inc. | 583.39M | 2.73% | 205,364 | - |
| 186 | TNGX | Tango Therapeutics, Inc. | 575.80M | -4.53% | 98,828 | 24.17M |
| 187 | FATE | Fate Therapeutics, Inc. | 575.25M | 11.70% | 2,368,647 | 69.01M |
| 188 | ARDX | Ardelyx, Inc. | 565.94M | -2.73% | 5,569,669 | 9.01M |
| 189 | IMAB | I-Mab | 565.07M | 6.08% | 382,539 | 18.23M |
| 190 | SRNE | Sorrento Therapeutics, Inc. | 553.36M | 5.21% | 10,396,894 | 60.32M |
| 191 | ARCT | Arcturus Therapeutics Holdings Inc. | 546.78M | 2.95% | 270,220 | 51.50M |
| 192 | ALVR | AlloVir, Inc. | 535.69M | -3.69% | 182,780 | - |
| 193 | ETNB | 89bio, Inc. | 535.18M | -0.78% | 437,483 | - |
| 194 | CALT | Calliditas Therapeutics AB | 532.34M | 1.48% | 4,072 | 33.64M |
| 195 | NUVB | Nuvation Bio, Inc. | 526.09M | -0.41% | 387,084 | - |
| 196 | RPTX | Repare Therapeutics, Inc. | 521.58M | -0.24% | 108,002 | 120.51M |
| 197 | TSVT | 2seventy bio, Inc. | 517.17M | 2.87% | 814,439 | 51.35M |
| 198 | PHAT | Phathom Pharmaceuticals, Inc. | 514.43M | 6.74% | 521,211 | - |
| 199 | HLVX | HilleVax, Inc. | 502.18M | -4.56% | 28,307 | - |
| 200 | OABI | OmniAb, Inc. | 501.32M | -2.24% | 353,402 | 51.57M |
| 201 | ATRA | Atara Biotherapeutics, Inc. | 500.01M | 6.68% | 785,993 | 70.90M |
| 202 | CMPX | Compass Therapeutics, Inc. | 497.19M | -0.25% | 367,036 | - |
| 203 | GHRS | GH Research PLC | 495.76M | 3.03% | 3,865 | - |
| 204 | MESO | Mesoblast Limited | 490.56M | -0.30% | 45,283 | 8.12M |
| 205 | NKTR | Nektar Therapeutics | 490.56M | 6.10% | 1,789,974 | 95.04M |
| 206 | SLN | Silence Therapeutics PLC | 484.56M | 4.01% | 18,811 | 16.15M |
| 207 | VERU | Veru Inc. | 475.68M | -0.17% | 1,760,148 | 39.35M |
| 208 | KZR | Kezar Life Sciences, Inc. | 472.65M | 2.53% | 348,342 | - |
| 209 | VECT | VectivBio Holding AG | 472.38M | 0.13% | 23,483 | - |
| 210 | THRX | Theseus Pharmaceuticals, Inc. | 469.59M | 2.80% | 95,543 | - |
| 211 | MLTX | MoonLake Immunotherapeutics | 465.78M | 3.55% | 24,728 | - |
| 212 | DSGN | Design Therapeutics, Inc. | 462.38M | -2.59% | 274,753 | - |
| 213 | ABUS | Arbutus Biopharma Corporation | 461.48M | - | 660,003 | 35.98M |
| 214 | ICVX | Icosavax, Inc. | 459.25M | 16.15% | 819,332 | 2.65M |
| 215 | VAXX | Vaxxinity, Inc. | 451.28M | 17.38% | 524,207 | -1.00K |
| 216 | CGEM | Cullinan Oncology, Inc. | 451.05M | 2.87% | 114,101 | - |
| 217 | CRBU | Caribou Biosciences, Inc. | 444.70M | 5.04% | 364,813 | 12.72M |
| 218 | VNDA | Vanda Pharmaceuticals Inc. | 432.91M | -0.52% | 285,844 | 257.92M |
| 219 | CDXS | Codexis, Inc. | 431.56M | 1.39% | 430,171 | 132.72M |
| 220 | STRO | Sutro Biopharma, Inc. | 431.07M | 0.13% | 294,646 | 69.79M |
| 221 | LQDA | Liquidia Corporation | 430.83M | -1.18% | 586,653 | 13.79M |
| 222 | TARS | Tarsus Pharmaceuticals, Inc. | 429.96M | 1.13% | 49,538 | 16.15M |
| 223 | MDXG | MiMedx Group, Inc. | 420.57M | -2.89% | 529,552 | 260.88M |
| 224 | INO | Inovio Pharmaceuticals, Inc. | 419.14M | 1.20% | 2,343,646 | 10.98M |
| 225 | LXRX | Lexicon Pharmaceuticals, Inc. | 418.97M | - | 321,087 | 125.00K |
| 226 | NGM | NGM Biopharmaceuticals, Inc. | 415.99M | -1.74% | 149,745 | - |
| 227 | KOD | Kodiak Sciences Inc. | 412.20M | -0.38% | 158,734 | - |
| 228 | CNCE | Concert Pharmaceuticals, Inc. | 402.91M | 0.72% | 1,165,777 | 42.00K |
| 229 | VIGL | Vigil Neuroscience, Inc. | 395.31M | 2.49% | 9,283 | - |
| 230 | ADCT | ADC Therapeutics SA | 392.11M | 6.99% | 344,156 | 157.12M |
| 231 | TERN | Terns Pharmaceuticals, Inc. | 391.67M | -1.74% | 107,942 | 1.00M |
| 232 | MGTX | MeiraGTx Holdings PLC | 385.39M | 7.87% | 226,305 | - |
| 233 | IRON | Disc Medicine, Inc. | 384.49M | 2.84% | 5,684 | - |
| 234 | ACET | Adicet Bio, Inc. | 383.95M | 0.79% | 265,800 | 30.46M |
| 235 | CCCC | C4 Therapeutics, Inc. | 383.82M | 2.35% | 218,251 | 48.32M |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 383.12M | 0.66% | 292,559 | 192.18M |
| 237 | PEPG | PepGen Inc. | 380.95M | -5.95% | 21,643 | - |
| 238 | STOK | Stoke Therapeutics, Inc. | 379.72M | 2.34% | 88,823 | 9.14M |
| 239 | TRDA | Entrada Therapeutics, Inc. | 378.76M | 3.34% | 17,706 | - |
| 240 | PMVP | PMV Pharmaceuticals, Inc. | 377.65M | - | 230,946 | - |
| 241 | ATXS | Astria Therapeutics, Inc. | 375.94M | -2.36% | 114,869 | - |
| 242 | WVE | Wave Life Sciences Ltd. | 374.58M | -3.58% | 239,361 | 4.18M |
| 243 | ALXO | ALX Oncology Holdings, Inc. | 374.14M | -2.34% | 126,817 | - |
| 244 | OMGA | Omega Therapeutics, Inc. | 373.34M | 0.13% | 22,803 | 1.48M |
| 245 | GBIO | Generation Bio Co. | 363.07M | 7.57% | 155,277 | - |
| 246 | AURA | Aura Biosciences, Inc. | 362.87M | 0.30% | 119,442 | - |
| 247 | TYRA | Tyra Biosciences, Inc. | 362.05M | 0.94% | 6,780 | - |
| 248 | GLUE | Monte Rosa Therapeutics, Inc. | 360.57M | 9.08% | 186,694 | - |
| 249 | KPTI | Karyopharm Therapeutics, Inc. | 360.02M | 1.60% | 1,415,304 | 249.76M |
| 250 | CNTA | Centessa Pharmaceuticals PLC | 357.57M | -5.50% | 1,216,732 | - |
| 251 | ALDX | Aldeyra Therapeutics, Inc. | 356.63M | 0.16% | 363,601 | - |
| 252 | FHTX | Foghorn Therapeutics, Inc. | 355.73M | 1.55% | 65,585 | 15.76M |
| 253 | ANNX | Annexon, Inc. | 355.32M | 2.05% | 217,453 | - |
| 254 | MGNX | MacroGenics, Inc. | 352.87M | -3.04% | 388,046 | 92.99M |
| 255 | RAIN | Rain Therapeutics, Inc. | 352.11M | 0.20% | 312,256 | - |
| 256 | ALPN | Alpine Immune Sciences, Inc. | 350.33M | -2.80% | 81,702 | 31.82M |
| 257 | VYGR | Voyager Therapeutics, Inc. | 347.85M | 0.22% | 251,116 | 70.53M |
| 258 | CABA | Cabaletta Bio, Inc. | 345.61M | 13.49% | 1,128,678 | - |
| 259 | PGEN | Precigen, Inc. | 341.37M | 1.23% | 3,349,354 | 75.88M |
| 260 | VOR | Vor Biopharma, Inc. | 340.06M | -1.33% | 44,580 | - |
| 261 | GTHX | G1 Therapeutics, Inc. | 339.61M | 2.13% | 443,517 | 46.85M |
| 262 | HRTX | Heron Therapeutics, Inc. | 331.70M | 7.31% | 2,176,580 | 98.30M |
| 263 | AUTL | Autolus Therapeutics PLC | 325.35M | 1.08% | 251,759 | 2.72M |
| 264 | KNTE | Kinnate Biopharma, Inc. | 323.29M | 2.52% | 66,217 | - |
| 265 | PHVS | Pharvaris, N.V | 319.63M | 0.42% | 38,178 | - |
| 266 | SEER | Seer, Inc. | 317.59M | 2.84% | 150,142 | 13.95M |
| 267 | SVRA | Savara, Inc. | 313.62M | 3.00% | 526,305 | - |
| 268 | AADI | Aadi Bioscience, Inc. | 312.50M | -0.47% | 61,437 | 10.99M |
| 269 | RIGL | Rigel Pharmaceuticals, Inc. | 311.10M | -3.74% | 2,787,941 | 89.37M |
| 270 | MRNS | Marinus Pharmaceuticals, Inc. | 310.61M | 5.39% | 214,200 | 19.84M |
| 271 | PRLD | Prelude Therapeutics, Inc. | 307.18M | -8.55% | 65,503 | - |
| 272 | QSI | Quantum-Si Incorporated | 306.20M | -1.35% | 445,023 | - |
| 273 | ACRV | Acrivon Therapeutics, Inc. | 303.46M | 1.68% | 1,440 | - |
| 274 | ABSI | Absci Corporation | 301.21M | -1.21% | 501,124 | 5.64M |
| 275 | OCUL | Ocular Therapeutix, Inc. | 298.80M | -0.26% | 567,851 | 49.73M |
| 276 | OTLK | Outlook Therapeutics, Inc. | 297.89M | 2.63% | 487,233 | - |
| 277 | ATAI | ATAI Life Sciences N.V. | 296.92M | -1.65% | 1,213,731 | 424.00K |
| 278 | ADAP | Adaptimmune Therapeutics PLC | 294.89M | 1.69% | 258,151 | 17.54M |
| 279 | ATNM | Actinium Pharmaceuticals, Inc. | 294.59M | 1.05% | 233,614 | 1.05M |
| 280 | IPHA | Innate Pharma S.A. | 290.18M | -0.29% | 16,413 | 57.48M |
| 281 | RANI | Rani Therapeutics Holdings, Inc. | 289.26M | -2.23% | 86,604 | - |
| 282 | HUMA | Humacyte, Inc. | 286.67M | 6.92% | 210,105 | 1.74M |
| 283 | LIAN | LianBio | 278.47M | 1.58% | 72,380 | - |
| 284 | DRTS | Alpha Tau Medical Ltd. | 278.12M | 0.75% | 39,287 | - |
| 285 | OCGN | Ocugen, Inc. | 277.99M | 5.83% | 4,176,868 | - |
| 286 | KALV | KalVista Pharmaceuticals, Inc. | 277.25M | -3.10% | 335,982 | - |
| 287 | DBVT | DBV Technologies S.A. | 275.11M | 4.55% | 115,277 | 9.87M |
| 288 | PDSB | PDS Biotechnology Corporation | 274.72M | 1.71% | 392,191 | - |
| 289 | IPSC | Century Therapeutics, Inc. | 273.05M | 1.76% | 99,934 | 4.68M |
| 290 | SELB | Selecta Biosciences, Inc. | 272.40M | 3.49% | 650,599 | 123.92M |
| 291 | BMEA | Biomea Fusion, Inc. | 271.62M | 3.30% | 51,569 | - |
| 292 | IVVD | Invivyd, Inc. | 270.28M | 3.77% | 304,642 | - |
| 293 | ORIC | Oric Pharmaceuticals Inc. | 268.90M | 4.79% | 145,328 | - |
| 294 | GRTS | Gritstone bio, Inc. | 268.44M | 5.92% | 998,526 | 18.75M |
| 295 | RLYB | Rallybio Corporation | 266.38M | -6.63% | 54,667 | - |
| 296 | MRKR | Marker Therapeutics, Inc. | 260.58M | - | 157,986 | 6.95M |
| 297 | OPT | Opthea Limited | 257.83M | 1.06% | 847 | 138.20K |
| 298 | IVA | Inventiva SA | 254.91M | -1.63% | 4,677 | 9.75M |
| 299 | GLSI | Greenwich LifeSciences, Inc. | 248.48M | 1.63% | 34,124 | - |
| 300 | FENC | Fennec Pharmaceuticals Inc. | 248.43M | -3.76% | 94,747 | - |
| 301 | NAUT | Nautilus Biotechnology, Inc. | 248.20M | 1.02% | 189,842 | - |
| 302 | NKTX | Nkarta, Inc. | 246.02M | -0.59% | 296,088 | - |
| 303 | ANTX | AN2 Therapeutics, Inc. | 243.89M | 2.11% | 11,016 | - |
| 304 | VERA | Vera Therapeutics, Inc. | 241.73M | -4.38% | 492,854 | - |
| 305 | XOMA | XOMA Corporation | 238.75M | -1.84% | 9,654 | 40.49M |
| 306 | LCTX | Lineage Cell Therapeutics, Inc. | 237.97M | 1.45% | 446,718 | 13.96M |
| 307 | MOLN | Molecular Partners AG | 237.17M | -2.28% | 4,193 | - |
| 308 | GOSS | Gossamer Bio, Inc. | 229.58M | 4.74% | 2,232,118 | - |
| 309 | CELC | Celcuity Inc. | 225.56M | -1.05% | 45,571 | - |
| 310 | PRAX | Praxis Precision Medicines, Inc. | 224.28M | 5.54% | 541,588 | - |
| 311 | ABOS | Acumen Pharmaceuticals, Inc. | 223.04M | -1.27% | 58,633 | - |
| 312 | TNYA | Tenaya Therapeutics, Inc. | 218.84M | 9.62% | 257,804 | - |
| 313 | GNFT | Genfit S.A. | 217.22M | 4.32% | 4,964 | 90.08M |
| 314 | URGN | UroGen Pharma Ltd. | 215.89M | 11.31% | 194,180 | 62.44M |
| 315 | PRQR | ProQR Therapeutics N.V. | 206.45M | 1.40% | 980,901 | 4.27M |
| 316 | LRMR | Larimar Therapeutics, Inc. | 202.07M | 11.19% | 58,880 | - |
| 317 | ACIU | AC Immune SA | 196.86M | -1.67% | 130,785 | 4.10M |
| 318 | PBYI | Puma Biotechnology Inc. | 196.51M | -4.07% | 234,692 | 217.71M |
| 319 | YMAB | Y-mAbs Therapeutics, Inc. | 193.89M | -2.42% | 331,454 | 43.42M |
| 320 | SCPH | scPharmaceuticals Inc. | 193.77M | -1.04% | 152,008 | - |
| 321 | VRCA | Verrica Pharmaceuticals Inc. | 193.55M | -1.05% | 70,091 | 8.96M |
| 322 | CTXR | Citius Pharmaceuticals, Inc. | 193.00M | 0.76% | 760,888 | - |
| 323 | OLMA | Olema Pharmaceuticals, Inc. | 190.54M | -0.63% | 106,451 | - |
| 324 | KMPH | KemPharm, Inc. | 190.12M | 4.36% | 183,227 | 10.72M |
| 325 | CTMX | CytomX Therapeutics, Inc. | 183.05M | -0.36% | 1,339,112 | 71.94M |
| 326 | AFMD | Affimed N.V. | 180.70M | 0.83% | 694,688 | 44.06M |
| 327 | OVID | Ovid Therapeutics Inc. | 178.28M | 2.02% | 61,107 | 1.46M |
| 328 | CRMD | CorMedix, Inc. | 177.93M | 5.19% | 240,312 | 92.10K |
| 329 | GLYC | GlycoMimetics, Inc. | 177.72M | 1.19% | 1,434,763 | 92.63K |
| 330 | TCRT | Alaunos Therapeutics, Inc. | 176.68M | 5.33% | 627,549 | 2.91M |
| 331 | IMMP | Immutep Limited | 175.82M | 3.63% | 54,289 | 4.69M |
| 332 | THRD | Third Harmonic Bio, Inc. | 173.13M | 0.47% | 86,796 | - |
| 333 | XERS | Xeris Pharmaceuticals, Inc. | 171.34M | 3.28% | 615,552 | 98.53M |
| 334 | BCAB | BioAtla, Inc. | 169.69M | - | 208,950 | - |
| 335 | OMER | Omeros Corporation | 169.37M | 6.72% | 328,325 | -79.89M |
| 336 | FREQ | Frequency Therapeutics, Inc. | 167.49M | -0.63% | 188,379 | - |
| 337 | BIVI | BioVie, Inc. | 164.01M | 0.40% | 213,733 | - |
| 338 | IKNA | Ikena Oncology, Inc. | 162.43M | 9.27% | 19,835 | 30.39M |
| 339 | GRNA | GreenLight Biosciences Holdings, PBC | 162.16M | 1.90% | 117,676 | 4.17M |
| 340 | EYPT | EyePoint Pharmaceuticals, Inc. | 161.21M | 5.35% | 98,802 | 42.42M |
| 341 | CMRX | Chimerix, Inc. | 158.48M | 1.12% | 364,454 | 33.06M |
| 342 | STTK | Shattuck Labs, Inc. | 157.27M | 3.06% | 41,845 | 30.34M |
| 343 | CDXC | ChromaDex Corporation | 157.13M | 8.21% | 209,291 | 68.81M |
| 344 | NBTX | Nanobiotix S.A. | 156.54M | 3.25% | 686 | 2.80M |
| 345 | ATHA | Athira Pharma, Inc. | 155.48M | 3.27% | 266,056 | - |
| 346 | VBIV | VBI Vaccines, Inc. | 154.44M | 4.00% | 435,192 | 870.00K |
| 347 | MACK | Merrimack Pharmaceuticals, Inc. | 153.55M | 0.35% | 115,376 | - |
| 348 | CELU | Celularity, Inc. | 152.26M | 7.68% | 495,669 | 18.70M |
| 349 | INMB | Inmune Bio Inc. | 149.85M | 1.09% | 51,169 | 440.00K |
| 350 | SLDB | Solid Biosciences Inc. | 149.19M | 2.55% | 27,263 | 11.25M |
| 351 | CUE | Cue Biopharma, Inc. | 148.07M | -2.69% | 65,561 | 9.35M |
| 352 | TRVI | Trevi Therapeutics, Inc. | 147.41M | 5.58% | 45,202 | - |
| 353 | GRCL | Gracell Biotechnologies, Inc. | 146.20M | 0.93% | 96,929 | 54.63K |
| 354 | VXRT | Vaxart, Inc. | 145.69M | 2.78% | 1,294,102 | 159.00K |
| 355 | KRON | Kronos Bio, Inc. | 145.66M | 8.02% | 322,389 | - |
| 356 | FUSN | Fusion Pharmaceuticals, Inc. | 145.48M | -1.52% | 343,946 | 1.92M |
| 357 | CLGN | CollPlant Biotechnologies Ltd. | 145.31M | 15.88% | 58,569 | 551.00K |
| 358 | BLI | Berkeley Lights, Inc. | 145.30M | 2.43% | 704,046 | 83.94M |
| 359 | CLLS | Cellectis S.A. | 141.25M | -1.27% | 97,362 | 24.11M |
| 360 | HOWL | Werewolf Therapeutics, Inc. | 140.53M | 6.49% | 165,859 | 9.12M |
| 361 | ANIX | Anixa Biosciences, Inc. | 137.91M | 1.25% | 44,601 | - |
| 362 | RVLP | RVL Pharmaceuticals plc | 137.82M | - | 36,312 | 42.77M |
| 363 | XBIT | XBiotech Inc. | 135.15M | -1.33% | 14,827 | 8.21M |
| 364 | VSTM | Verastem, Inc. | 132.86M | -3.09% | 1,150,928 | 3.14M |
| 365 | DTIL | Precision BioSciences, Inc. | 129.82M | 0.86% | 780,123 | 20.84M |
| 366 | MNMD | Mind Medicine (MindMed), Inc. | 129.24M | 0.88% | 450,789 | - |
| 367 | SESN | Sesen Bio, Inc. | 127.86M | 2.77% | 623,458 | 60.00M |
| 368 | MTNB | Matinas BioPharma Holdings, Inc. | 127.82M | -0.10% | 236,842 | - |
| 369 | XFOR | X4 Pharmaceuticals, Inc. | 127.61M | 2.94% | 294,000 | - |
| 370 | PIRS | Pieris Pharmaceuticals, Inc. | 126.49M | 1.80% | 522,812 | 28.50M |
| 371 | MREO | Mereo BioPharma Group PLC | 124.99M | 1.01% | 278,246 | - |
| 372 | ANVS | Annovis Bio, Inc. | 124.50M | 11.31% | 156,892 | - |
| 373 | RLMD | Relmada Therapeutics, Inc. | 124.01M | -1.67% | 144,195 | - |
| 374 | EPIX | ESSA Pharma Inc. | 123.40M | 4.48% | 234,509 | - |
| 375 | AKBA | Akebia Therapeutics, Inc. | 123.25M | -5.63% | 2,619,103 | 297.03M |
| 376 | GMDA | Gamida Cell Ltd. | 120.82M | 4.52% | 473,533 | - |
| 377 | MNOV | MediciNova, Inc. | 120.65M | -0.40% | 32,631 | - |
| 378 | MIST | Milestone Pharmaceuticals Inc. | 120.00M | 1.45% | 563,351 | 1.50M |
| 379 | CVM | Cel-Sci Corporation | 119.68M | 2.62% | 72,838 | - |
| 380 | SLGL | Sol-Gel Technologies Ltd. | 119.35M | -2.64% | 22,899 | 24.59M |
| 381 | ARMP | Armata Pharmaceuticals, Inc. | 118.92M | -3.52% | 31,732 | 5.45M |
| 382 | XLO | Xilio Therapeutics, Inc. | 117.58M | 3.63% | 103,909 | - |
| 383 | IMRX | Immuneering Corporation | 117.50M | 0.91% | 33,484 | 506.09K |
| 384 | BCTX | BriaCell Therapeutics Corp. | 117.16M | 0.40% | 191,380 | - |
| 385 | NVCT | Nuvectis Pharma, Inc. | 116.85M | 9.02% | 161,721 | - |
| 386 | PRTK | Paratek Pharmaceuticals, Inc. | 116.10M | -0.95% | 205,393 | 116.51M |
| 387 | SPPI | Spectrum Pharmaceuticals, Inc. | 115.66M | -2.70% | 831,233 | - |
| 388 | DARE | Dare Bioscience, Inc. | 114.94M | -0.37% | 661,405 | 10.00M |
| 389 | EVLO | Evelo Biosciences, Inc. | 114.00M | 1.96% | 60,950 | - |
| 390 | PRDS | Pardes Biosciences, Inc. | 112.97M | 7.02% | 401,250 | - |
| 391 | GRPH | Graphite Bio, Inc. | 112.82M | 0.52% | 119,084 | - |
| 392 | IPA | ImmunoPrecise Antibodies Ltd. | 110.71M | 0.68% | 11,143 | 14.44M |
| 393 | VACC | Vaccitech plc | 110.02M | -3.28% | 38,148 | 38.25M |
| 394 | TSHA | Taysha Gene Therapies, Inc. | 109.90M | -4.86% | 719,391 | - |
| 395 | BDTX | Black Diamond Therapeutics, Inc. | 109.10M | 0.33% | 41,161 | - |
| 396 | CLNN | Clene, Inc. | 108.52M | 13.08% | 139,381 | 438.00K |
| 397 | IMRA | IMARA Inc. | 107.52M | -3.99% | 71,601 | - |
| 398 | ONCY | Oncolytics Biotech Inc. | 107.43M | 3.41% | 110,017 | - |
| 399 | ARAV | Aravive, Inc. | 107.09M | 4.68% | 109,572 | 8.65M |
| 400 | CAPR | Capricor Therapeutics, Inc. | 107.02M | 0.95% | 207,174 | 1.59M |
| 401 | OPNT | Opiant Pharmaceuticals, Inc. | 106.74M | -0.10% | 65,779 | 22.34M |
| 402 | TIL | Instil Bio, Inc. | 105.96M | 4.57% | 623,757 | - |
| 403 | GNTA | Genenta Science S.p.A. | 105.66M | -3.17% | 100 | - |
| 404 | ATOS | Atossa Therapeutics, Inc. | 103.83M | 0.95% | 354,912 | - |
| 405 | ELYM | Eliem Therapeutics, Inc. | 102.29M | - | 190 | - |
| 406 | FBIO | Fortress Biotech, Inc. | 101.13M | 4.62% | 450,272 | 77.62M |
| 407 | IFRX | InflaRx N.V. | 99.46M | 4.17% | 167,536 | - |
| 408 | IMUX | Immunic, Inc. | 99.36M | 8.21% | 1,807,125 | - |
| 409 | BYSI | BeyondSpring, Inc. | 98.49M | -1.17% | 161,466 | 1.35M |
| 410 | INZY | Inozyme Pharma, Inc. | 96.14M | 13.33% | 1,613,691 | - |
| 411 | SPRO | Spero Therapeutics, Inc. | 94.23M | -1.62% | 210,642 | 8.81M |
| 412 | FSTX | F-star Therapeutics, Inc. | 92.54M | -2.77% | 1,108,042 | 21.18M |
| 413 | SYRS | Syros Pharmaceuticals, Inc. | 91.02M | 1.81% | 90,969 | 23.44M |
| 414 | ETON | Eton Pharmaceuticals, Inc. | 90.82M | -1.37% | 80,393 | 19.84M |
| 415 | LVTX | LAVA Therapeutics N.V. | 89.38M | -2.30% | 21,363 | 18.96M |
| 416 | LBPH | Longboard Pharmaceuticals, Inc. | 89.35M | -1.14% | 17,143 | - |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 89.13M | -1.13% | 71,596 | - |
| 418 | ACHV | Achieve Life Sciences, Inc. | 88.41M | 4.88% | 70,184 | - |
| 419 | PRTG | Portage Biotech, Inc. | 87.72M | -3.02% | 55,396 | - |
| 420 | LGVN | Longeveron, Inc. | 87.44M | -4.59% | 97,560 | 1.31M |
| 421 | SEEL | Seelos Therapeutics, Inc. | 87.06M | -2.97% | 571,629 | - |
| 422 | CDTX | Cidara Therapeutics, Inc. | 86.66M | - | 1,577,323 | 61.29M |
| 423 | FIXX | Homology Medicines, Inc. | 86.22M | -1.96% | 86,203 | 3.21M |
| 424 | IMPL | Impel NeuroPharma, Inc. | 85.22M | 1.99% | 8,007 | 8.22M |
| 425 | LYRA | Lyra Therapeutics, Inc. | 84.98M | -2.20% | 26,688 | 1.62M |
| 426 | ADAG | Adagene, Inc. | 84.68M | 1.30% | 68,094 | 12.74M |
| 427 | PASG | Passage Bio, Inc. | 83.47M | - | 271,924 | - |
| 428 | ASMB | Assembly Biosciences, Inc. | 83.41M | 1.79% | 365,684 | - |
| 429 | DBTX | Decibel Therapeutics, Inc. | 83.38M | 4.05% | 18,520 | - |
| 430 | NRXP | NRx Pharmaceuticals, Inc. | 83.26M | -1.60% | 245,481 | - |
| 431 | MDWD | MediWound Ltd. | 82.46M | 2.09% | 65,560 | 20.37M |
| 432 | ENLV | Enlivex Therapeutics Ltd. | 81.38M | 3.03% | 4,992 | - |
| 433 | IOBT | IO Biotech, Inc. | 81.26M | 1.08% | 21,892 | - |
| 434 | VIRX | Viracta Therapeutics, Inc. | 80.98M | 1.44% | 67,249 | - |
| 435 | ALGS | Aligos Therapeutics, Inc. | 80.92M | - | 125,297 | - |
| 436 | VTVT | vTv Therapeutics Inc. | 80.67M | 1.41% | 24,041 | 2.02M |
| 437 | CLSD | Clearside Biomedical, Inc. | 80.05M | - | 121,755 | 26.68M |
| 438 | RZLT | Rezolute, Inc. | 79.92M | 5.34% | 23,551 | - |
| 439 | PLX | Protalix BioTherapeutics, Inc. | 79.54M | 3.29% | 634,582 | 47.57M |
| 440 | SNTI | Senti Biosciences, Inc. | 78.18M | -2.58% | 444,400 | - |
| 441 | CRDF | Cardiff Oncology, Inc. | 77.74M | 0.58% | 122,822 | 391.00K |
| 442 | CADL | Candel Therapeutics, Inc. | 77.15M | 6.80% | 28,970 | - |
| 443 | MLEC | Moolec Science SA | 76.68M | 1.32% | 26,724 | - |
| 444 | EYEN | Eyenovia, Inc. | 76.22M | 0.48% | 115,258 | 10.00M |
| 445 | ORMP | Oramed Pharmaceuticals Inc. | 75.88M | 0.52% | 1,515,050 | 2.93M |
| 446 | INKT | MiNK Therapeutics, Inc. | 75.66M | 1.36% | 8,150 | - |
| 447 | AMAM | Ambrx Biopharma, Inc. | 75.31M | 2.63% | 225,504 | 5.24M |
| 448 | CGEN | Compugen Ltd. | 75.22M | -0.32% | 417,329 | - |
| 449 | CRIS | Curis, Inc. | 75.14M | 3.23% | 1,132,628 | 10.41M |
| 450 | MBIO | Mustang Bio, Inc. | 74.52M | -1.28% | 271,109 | - |
| 451 | NCNA | NuCana PLC | 73.60M | 1.44% | 46,268 | - |
| 452 | HCWB | HCW Biologics, Inc. | 73.55M | -0.47% | 7,904 | 2.32M |
| 453 | ORTX | Orchard Therapeutics PLC | 71.71M | -5.62% | 457,511 | 16.15M |
| 454 | MIRO | Miromatrix Medical, Inc. | 71.70M | 4.89% | 17,749 | 31.12K |
| 455 | OCUP | Ocuphire Pharma, Inc. | 70.95M | 13.29% | 337,888 | - |
| 456 | CYBN | Cybin, Inc. | 70.61M | -2.46% | 1,210,223 | - |
| 457 | CNTB | Connect Biopharma Holdings Limited | 70.42M | -0.78% | 54,324 | - |
| 458 | APTO | Aptose Biosciences, Inc. | 70.14M | 7.07% | 369,012 | - |
| 459 | ADVM | Adverum Biotechnologies, Inc. | 69.24M | 4.41% | 233,060 | - |
| 460 | SPRB | Spruce Biosciences, Inc. | 69.03M | -5.18% | 178,660 | - |
| 461 | LIFE | aTyr Pharma, Inc. | 68.75M | -3.27% | 252,354 | - |
| 462 | ANEB | Anebulo Pharmaceuticals, Inc. | 68.19M | -12.21% | 28,969 | - |
| 463 | ONCT | Oncternal Therapeutics, Inc. | 67.71M | 1.58% | 92,417 | 1.88M |
| 464 | SLS | SELLAS Life Sciences Group, Inc. | 66.91M | -4.41% | 183,360 | 1.00M |
| 465 | SYBX | Synlogic, Inc. | 66.29M | -2.08% | 108,356 | 1.67M |
| 466 | GALT | Galectin Therapeutics Inc. | 66.26M | - | 94,522 | - |
| 467 | TLSA | Tiziana Life Sciences Ltd | 66.20M | -2.59% | 45,286 | - |
| 468 | TNXP | Tonix Pharmaceuticals Holding Corp. | 66.17M | - | 1,665,033 | - |
| 469 | RPHM | Reneo Pharmaceuticals, Inc. | 65.74M | -1.11% | 37,346 | - |
| 470 | JSPR | Jasper Therapeutics, Inc. | 64.51M | -3.33% | 779,263 | - |
| 471 | GNPX | Genprex, Inc. | 64.35M | 2.29% | 95,168 | - |
| 472 | MYMD | MyMD Pharmaceuticals, Inc. | 64.34M | 8.67% | 304,091 | - |
| 473 | HEPA | Hepion Pharmaceuticals, Inc. | 64.01M | 1.93% | 866,427 | - |
| 474 | IMNM | Immunome, Inc. | 63.92M | 4.36% | 43,945 | - |
| 475 | ALZN | Alzamend Neuro, Inc. | 63.64M | -2.78% | 299,661 | - |
| 476 | UBX | Unity Biotechnology, Inc. | 63.58M | 3.94% | 175,795 | 5.02M |
| 477 | LPTX | Leap Therapeutics, Inc. | 63.44M | -4.33% | 343,913 | 375.00K |
| 478 | EIGR | Eiger BioPharmaceuticals, Inc. | 62.59M | 1.43% | 397,467 | 14.15M |
| 479 | JNCE | Jounce Therapeutics, Inc. | 61.52M | 5.31% | 514,749 | - |
| 480 | BCEL | Atreca, Inc. | 61.34M | -0.63% | 46,750 | - |
| 481 | ORGS | Orgenesis Inc. | 61.31M | -0.83% | 23,751 | 29.29M |
| 482 | GRTX | Galera Therapeutics, Inc. | 60.99M | 3.88% | 132,794 | - |
| 483 | CYT | Cyteir Therapeutics, Inc. | 60.42M | 7.23% | 49,439 | - |
| 484 | SURF | Surface Oncology, Inc. | 59.32M | 6.50% | 106,928 | 30.16M |
| 485 | CGTX | Cognition Therapeutics, Inc. | 58.56M | 0.50% | 41,879 | - |
| 486 | KA | Kineta, Inc. | 58.22M | -10.60% | 14,840 | 4.84M |
| 487 | APLT | Applied Therapeutics, Inc. | 58.15M | 6.14% | 197,480 | - |
| 488 | LTRN | Lantern Pharma, Inc. | 57.76M | -1.66% | 12,759 | - |
| 489 | ICCC | ImmuCell Corporation | 57.33M | -2.25% | 1,563 | 20.46M |
| 490 | TCRR | TCR2 Therapeutics Inc. | 57.21M | 7.25% | 175,131 | - |
| 491 | ENOB | Enochian Biosciences, Inc. | 57.19M | - | 46,195 | - |
| 492 | INFI | Infinity Pharmaceuticals, Inc. | 57.18M | -1.54% | 439,825 | 2.50M |
| 493 | GLTO | Galecto, Inc. | 56.28M | 7.32% | 72,454 | - |
| 494 | INAB | IN8bio, Inc. | 55.87M | 10.14% | 59,498 | - |
| 495 | PYXS | Pyxis Oncology, Inc. | 55.80M | -0.63% | 10,316 | - |
| 496 | CSBR | Champions Oncology, Inc. | 55.73M | 1.48% | 7,900 | 54.10M |
| 497 | BCLI | Brainstorm Cell Therapeutics Inc. | 55.54M | -1.30% | 152,546 | - |
| 498 | BOLT | Bolt Biotherapeutics, Inc. | 55.36M | 0.68% | 124,313 | 4.83M |
| 499 | PMCB | PharmaCyte Biotech, Inc. | 55.06M | 1.03% | 64,162 | - |
| 500 | HOOK | HOOKIPA Pharma Inc. | 54.72M | - | 209,630 | 10.32M |
| 501 | ICU | SeaStar Medical Holding Corporation | 54.61M | -2.93% | 38,678 | - |
| 502 | TALS | Talaris Therapeutics, Inc. | 54.04M | -2.19% | 319,148 | - |
| 503 | ASLN | ASLAN Pharmaceuticals Limited | 51.95M | 2.04% | 52,595 | - |
| 504 | CKPT | Checkpoint Therapeutics, Inc. | 51.87M | -1.75% | 169,769 | 134.00K |
| 505 | AXLA | Axcella Health, Inc. | 50.97M | -10.00% | 962,737 | - |
| 506 | MDNA | Medicenna Therapeutics Corp. | 50.84M | -2.00% | 262,245 | - |
| 507 | OCX | OncoCyte Corporation | 50.42M | -3.41% | 412,423 | 8.10M |
| 508 | NLSP | NLS Pharmaceutics Ltd. | 50.41M | -0.47% | 102,259 | - |
| 509 | DYAI | Dyadic International, Inc. | 49.99M | 1.16% | 31,629 | 2.50M |
| 510 | MAIA | MAIA Biotechnology, Inc. | 49.09M | 7.30% | 16,549 | - |
| 511 | BCDA | BioCardia, Inc. | 48.51M | 2.98% | 50,689 | 1.33M |
| 512 | GANX | Gain Therapeutics, Inc. | 48.37M | -4.24% | 40,543 | 183.32K |
| 513 | ACHL | Achilles Therapeutics plc | 48.31M | 2.61% | 170,883 | - |
| 514 | OKYO | OKYO Pharma Limited | 48.22M | -3.28% | 164 | - |
| 515 | LPCN | Lipocine Inc. | 47.32M | 2.81% | 118,330 | 16.59M |
| 516 | PMN | ProMIS Neurosciences Inc. | 46.59M | -0.73% | 887 | - |
| 517 | ACER | Acer Therapeutics Inc. | 46.49M | -2.48% | 226,854 | 360.00K |
| 518 | SNSE | Sensei Biotherapeutics, Inc. | 46.39M | 5.59% | 28,015 | - |
| 519 | NXTC | NextCure, Inc. | 46.38M | 3.73% | 224,239 | - |
| 520 | ABEO | Abeona Therapeutics Inc. | 45.52M | 1.15% | 196,806 | 4.35M |
| 521 | ELDN | Eledon Pharmaceuticals, Inc. | 45.26M | -0.45% | 5,354 | - |
| 522 | MNPR | Monopar Therapeutics, Inc. | 45.22M | 1.16% | 118,328 | - |
| 523 | PLUR | Pluri Inc. | 44.93M | -3.36% | 22,092 | 321.00K |
| 524 | ACXP | Acurx Pharmaceuticals, Inc. | 44.52M | -0.78% | 24,575 | - |
| 525 | APGN | Apexigen, Inc. | 44.45M | -7.51% | 354,583 | - |
| 526 | COYA | Coya Therapeutics, Inc. | 43.94M | -1.52% | 12,610 | - |
| 527 | VTGN | VistaGen Therapeutics, Inc. | 43.83M | 10.54% | 8,699,854 | -185.60K |
| 528 | BIOR | Biora Therapeutics, Inc. | 43.40M | 7.67% | 618,695 | 726.00K |
| 529 | TCRX | TScan Therapeutics, Inc. | 43.10M | 3.47% | 141,549 | 13.29M |
| 530 | PTN | Palatin Technologies, Inc. | 41.62M | -1.47% | 75,525 | 2.18M |
| 531 | MEIP | MEI Pharma, Inc. | 41.20M | -4.83% | 481,819 | 41.67M |
| 532 | BLRX | BioLineRx Ltd. | 39.34M | -2.37% | 302,580 | - |
| 533 | HARP | Harpoon Therapeutics, Inc. | 39.21M | 25.53% | 2,220,368 | 32.15M |
| 534 | QNCX | Quince Therapeutics, Inc. | 39.02M | 33.66% | 63,633,713 | - |
| 535 | AVRO | Avrobio, Inc. | 38.92M | 3.31% | 144,028 | - |
| 536 | DMAC | DiaMedica Therapeutics Inc. | 38.87M | -1.34% | 8,868 | - |
| 537 | EVAX | Evaxion Biotech A/S | 38.86M | 1.90% | 160,628 | - |
| 538 | FRLN | Freeline Therapeutics Holdings PLC | 38.83M | -2.67% | 191,779 | - |
| 539 | CRVS | Corvus Pharmaceuticals, Inc. | 38.56M | -0.20% | 95,674 | - |
| 540 | TBIO | Telesis Bio Inc. | 38.38M | -94.94% | 19,869 | 21.04M |
| 541 | AVTX | Avalo Therapeutics, Inc. | 37.66M | -0.74% | 10,759 | 17.37M |
| 542 | TCON | TRACON Pharmaceuticals, Inc. | 37.65M | -0.88% | 43,780 | - |
| 543 | AKTX | Akari Therapeutics, PLC | 37.22M | -5.32% | 128,780 | - |
| 544 | NYMX | Nymox Pharmaceutical Corporation | 37.11M | -4.65% | 140,748 | - |
| 545 | MBRX | Moleculin Biotech, Inc. | 36.36M | -1.55% | 21,381 | - |
| 546 | NOVN | Novan, Inc. | 35.47M | 3.57% | 149,612 | 13.86M |
| 547 | EQ | Equillium, Inc. | 34.93M | -2.40% | 102,924 | - |
| 548 | TARA | Protara Therapeutics, Inc. | 34.93M | -1.90% | 22,283 | - |
| 549 | TFFP | TFF Pharmaceuticals, Inc. | 34.20M | -0.52% | 59,466 | 195.02K |
| 550 | SABS | SAB Biotherapeutics Inc. | 33.88M | 0.34% | 35,031 | 32.80M |
| 551 | IMMX | Immix Biopharma, Inc. | 33.43M | -0.41% | 76,638 | - |
| 552 | SIOX | Sio Gene Therapies, Inc. | 32.73M | 0.29% | 495,816 | - |
| 553 | STSA | Satsuma Pharmaceuticals, Inc. | 32.53M | 1.25% | 84,310 | - |
| 554 | BTTX | Better Therapeutics, Inc. | 32.20M | -5.17% | 33,685 | - |
| 555 | EVGN | Evogene Ltd. | 32.15M | 4.00% | 57,843 | 1.33M |
| 556 | BNOX | Bionomics Limited | 32.14M | -1.27% | 40,453 | 183.08K |
| 557 | ABIO | ARCA biopharma, Inc. | 31.99M | -2.20% | 40,078 | - |
| 558 | ACST | Acasti Pharma Inc. | 31.86M | -0.49% | 117,149 | - |
| 559 | AGLE | Aeglea Biotherapeutics, Inc. | 31.37M | 3.45% | 287,362 | 5.81M |
| 560 | GTBP | GT Biopharma, Inc | 30.73M | 1.58% | 177,670 | - |
| 561 | NHWK | NightHawk Biosciences, Inc. | 30.54M | -1.65% | 40,343 | 6.92M |
| 562 | CMRA | Comera Life Sciences Holdings, Inc. | 30.50M | -2.84% | 238,710 | - |
| 563 | CVKD | Cadrenal Therapeutics, Inc. | 30.48M | -7.75% | 114,812 | - |
| 564 | PPBT | Purple Biotech Ltd. | 30.15M | 1.86% | 20,166 | - |
| 565 | VCNX | Vaccinex, Inc. | 30.00M | 1.93% | 63,686 | 50.00K |
| 566 | MTEM | Molecular Templates, Inc. | 29.87M | 0.32% | 75,074 | 35.11M |
| 567 | AGE | AgeX Therapeutics, Inc. | 29.82M | -1.79% | 18,794 | 53.00K |
| 568 | ZIVO | Zivo Bioscience Inc. | 29.58M | 2.61% | 2,061 | - |
| 569 | PXMD | PaxMedica, Inc. | 29.25M | -10.00% | 356,288 | - |
| 570 | CYCN | Cyclerion Therapeutics, Inc. | 29.21M | -2.71% | 55,032 | 1.55M |
| 571 | CYAD | Celyad Oncology SA | 29.15M | -15.69% | 147,743 | - |
| 572 | LUMO | Lumos Pharma, Inc. | 28.90M | -4.30% | 29,209 | 1.23M |
| 573 | EDSA | Edesa Biotech, Inc. | 28.64M | -2.63% | 113,745 | - |
| 574 | APTX | Aptinyx Inc. | 28.44M | 3.58% | 59,089 | - |
| 575 | MGTA | Magenta Therapeutics, Inc. | 27.98M | 5.00% | 922,928 | - |
| 576 | NTRB | Nutriband Inc. | 27.96M | 6.57% | 25,341 | 2.04M |
| 577 | LSTA | Lisata Therapeutics, Inc. | 27.90M | -0.28% | 6,326 | - |
| 578 | CASI | CASI Pharmaceuticals, Inc. | 27.76M | 0.99% | 12,233 | 37.01M |
| 579 | NMTR | 9 Meters Biopharma, Inc. | 27.49M | -1.76% | 39,961 | - |
| 580 | COEP | Coeptis Therapeutics, Inc. | 27.30M | 5.33% | 37,484 | 75.00K |
| 581 | VINC | Vincerx Pharma, Inc. | 27.12M | -2.29% | 101,882 | - |
| 582 | ATHX | Athersys, Inc. | 27.02M | 12.95% | 487,704 | 6.02M |
| 583 | AIM | AIM ImmunoTech, Inc. | 26.93M | -5.12% | 256,201 | 134.00K |
| 584 | GLS | Gelesis Holdings, Inc. | 26.31M | -2.65% | 134,332 | 26.03M |
| 585 | ENTX | Entera Bio Ltd. | 25.96M | -3.39% | 24,008 | 285.00K |
| 586 | CDAK | Codiak BioSciences, Inc. | 25.41M | 2.97% | 126,899 | 34.07M |
| 587 | RUBY | Rubius Therapeutics, Inc. | 25.30M | 0.68% | 498,491 | - |
| 588 | IMV | IMV Inc. | 25.24M | 0.93% | 90,403 | 159.85K |
| 589 | APRE | Aprea Therapeutics, Inc. | 25.12M | -0.65% | 62,458 | - |
| 590 | FNCH | Finch Therapeutics Group, Inc. | 24.91M | 9.47% | 365,235 | 1.66M |
| 591 | AMTI | Applied Molecular Transport, Inc. | 24.85M | 1.92% | 100,905 | - |
| 592 | ERNA | Eterna Therapeutics Inc. | 24.82M | - | 5,220 | - |
| 593 | ABVC | ABVC BioPharma, Inc. | 24.80M | -1.85% | 40,654 | 343.00K |
| 594 | RGLS | Regulus Therapeutics Inc. | 24.76M | -3.92% | 68,492 | - |
| 595 | RNXT | RenovoRx, Inc. | 24.11M | 6.00% | 20,205 | - |
| 596 | SQZ | SQZ Biotechnologies Company | 24.08M | -2.68% | 213,767 | 21.89M |
| 597 | CMMB | Chemomab Therapeutics Ltd. | 23.97M | -7.96% | 74,713 | - |
| 598 | ELEV | Elevation Oncology, Inc. | 23.77M | -1.92% | 11,675 | - |
| 599 | SLNO | Soleno Therapeutics, Inc. | 22.93M | 8.49% | 110,083 | - |
| 600 | COCP | Cocrystal Pharma, Inc. | 22.07M | -3.90% | 58,796 | - |
| 601 | GOVX | GeoVax Labs, Inc. | 21.86M | 10.50% | 5,546,165 | 246.49K |
| 602 | OBSV | ObsEva SA | 21.56M | 2.56% | 819,731 | - |
| 603 | ERYP | Erytech Pharma S.A. | 21.48M | 7.45% | 38,817 | 28.65M |
| 604 | TPST | Tempest Therapeutics, Inc. | 21.45M | 1.49% | 5,559 | - |
| 605 | SGTX | Sigilon Therapeutics, Inc. | 21.43M | -5.69% | 104,401 | 12.29M |
| 606 | SRZN | Surrozen, Inc. | 21.41M | - | 409,438 | - |
| 607 | DOMH | Dominari Holdings Inc. | 21.39M | 1.83% | 15,369 | - |
| 608 | ANGN | Angion Biomedica Corp. | 21.34M | - | 179,220 | 28.24M |
| 609 | EFTR | eFFECTOR Therapeutics, Inc. | 21.32M | 4.35% | 210,598 | 3.19M |
| 610 | FBRX | Forte Biosciences, Inc. | 21.21M | - | 47,607 | - |
| 611 | SNGX | Soligenix, Inc. | 20.78M | 0.44% | 50,033 | 858.50K |
| 612 | MTCR | Metacrine, Inc. | 20.44M | - | 845,721 | - |
| 613 | KTTA | Pasithea Therapeutics Corp. | 20.38M | -0.26% | 87,419 | 260.91K |
| 614 | ADXN | Addex Therapeutics Ltd. | 20.38M | 1.92% | 304,269 | 1.28M |
| 615 | BLPH | Bellerophon Therapeutics, Inc. | 20.05M | - | 35,860 | - |
| 616 | BWV | Blue Water Vaccines, Inc. | 19.96M | 0.78% | 107,756 | - |
| 617 | NRSN | NeuroSense Therapeutics Ltd. | 19.91M | 1.81% | 102,406 | - |
| 618 | ZVSA | ZyVersa Therapeutics, Inc. | 19.07M | -2.33% | 46,026 | - |
| 619 | KZIA | Kazia Therapeutics Limited | 18.88M | -1.96% | 32,193 | 18.75K |
| 620 | ARDS | Aridis Pharmaceuticals Inc. | 18.44M | -11.26% | 3,057,888 | 2.87M |
| 621 | HGEN | Humanigen Inc. | 18.33M | 2.26% | 2,380,935 | 3.33M |
| 622 | APM | Aptorum Group Limited | 18.29M | -0.19% | 5,487 | 1.43M |
| 623 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 18.13M | 3.36% | 1,279,519 | - |
| 624 | AEZS | AEterna Zentaris Inc. | 18.11M | 1.36% | 9,774 | 6.63M |
| 625 | ONTX | Onconova Therapeutics, Inc. | 17.81M | -1.66% | 74,487 | 226.00K |
| 626 | BPTH | Bio-Path Holdings, Inc. | 17.63M | 2.07% | 65,108 | - |
| 627 | LEXX | Lexaria Bioscience Corp. | 17.50M | 4.26% | 24,745 | 342.99K |
| 628 | LABP | Landos Biopharma, Inc. | 17.38M | -1.86% | 140,803 | - |
| 629 | ANPC | AnPac Bio-Medical Science Co. Ltd. | 17.35M | -4.17% | 34,329 | 2.21M |
| 630 | ATHE | Alterity Therapeutics Limited | 17.05M | 2.62% | 25,947 | - |
| 631 | NNVC | NanoViricides, Inc. | 16.95M | 0.69% | 10,416 | - |
| 632 | IKT | Inhibikase Therapeutics, Inc. | 16.60M | -7.32% | 419,672 | 61.82K |
| 633 | GLMD | Galmed Pharmaceuticals Ltd. | 16.41M | -5.60% | 52,695 | - |
| 634 | PYPD | PolyPid Ltd. | 16.34M | -7.24% | 398,041 | - |
| 635 | REUN | Reunion Neuroscience Inc. | 16.07M | - | 82,834 | 3.08M |
| 636 | NRBO | NeuroBo Pharmaceuticals, Inc. | 15.36M | 1.00% | 948,994 | - |
| 637 | TTNP | Titan Pharmaceuticals, Inc. | 15.36M | 2.94% | 84,425 | 572.00K |
| 638 | AIMD | Ainos Inc. | 15.01M | 0.01% | 4,844 | 2.51M |
| 639 | PSTV | Plus Therapeutics, Inc. | 14.86M | 0.50% | 207,287 | 73.00K |
| 640 | PULM | Pulmatrix, Inc. | 14.81M | 2.01% | 23,157 | 4.82M |
| 641 | ITRM | Iterum Therapeutics PLC | 14.80M | 1.68% | 52,186 | - |
| 642 | VYNE | VYNE Therapeutics, Inc. | 14.80M | 7.59% | 486,289 | 2.76M |
| 643 | ACGN | Aceragen, Inc. | 14.76M | -2.89% | 20,506 | - |
| 644 | GRAY | Graybug Vision, Inc. | 14.66M | -6.02% | 12,726 | - |
| 645 | CLRB | Cellectar BioSciences, Inc. | 14.45M | 3.36% | 32,220 | - |
| 646 | TOVX | Theriva Biologics, Inc. | 14.34M | 0.56% | 145,023 | - |
| 647 | DRUG | Bright Minds Biosciences Inc. | 14.22M | 0.01% | 154,161 | - |
| 648 | PCSA | Processa Pharmaceuticals, Inc. | 14.07M | -11.90% | 125,562 | - |
| 649 | INDP | Indaptus Therapeutics, Inc. | 14.03M | -1.18% | 9,426 | - |
| 650 | ONVO | Organovo Holdings, Inc. | 13.85M | - | 21,463 | 1.58M |
| 651 | LIPO | Lipella Pharmaceuticals Inc. | 13.84M | -3.60% | 51,207 | 259.35K |
| 652 | IMRN | Immuron Limited | 13.37M | 5.12% | 8,292 | 531.38K |
| 653 | TRVN | Trevena, Inc. | 13.19M | -1.72% | 103,465 | -419.00K |
| 654 | ALRN | Aileron Therapeutics, Inc. | 13.03M | -3.37% | 15,151 | - |
| 655 | CANF | Can-Fite BioPharma Ltd. | 12.93M | 0.49% | 48,743 | 248.55K |
| 656 | DFFN | Diffusion Pharmaceuticals, Inc. | 12.62M | 2.65% | 6,798 | - |
| 657 | NERV | Minerva Neurosciences, Inc. | 12.60M | 6.79% | 47,079 | - |
| 658 | LMNL | Liminal BioSciences Inc. | 12.43M | -1.50% | 16,437 | 301.52K |
| 659 | APVO | Aptevo Therapeutics Inc. | 12.17M | 0.42% | 62,673 | 6.78M |
| 660 | LIXT | Lixte Biotechnology Holdings, Inc. | 12.17M | -3.74% | 44,601 | - |
| 661 | OGEN | Oragenics Inc. | 12.16M | -3.28% | 23,052 | 218.51K |
| 662 | ATNF | 180 Life Sciences Corp. | 12.11M | -10.50% | 930,697 | - |
| 663 | IMNN | Imunon, Inc. | 11.60M | 4.00% | 106,263 | 500.00K |
| 664 | NEXI | NexImmune, Inc. | 11.47M | 14.35% | 424,000 | - |
| 665 | CNTX | Context Therapeutics, Inc. | 11.18M | -3.13% | 108,813 | - |
| 666 | CBIO | Catalyst Biosciences, Inc. | 11.14M | -2.99% | 569,804 | 3.23M |
| 667 | BRTX | BioRestorative Therapies, Inc. | 11.06M | -0.33% | 3,841 | 121.10K |
| 668 | CYCC | Cyclacel Pharmaceuticals, Inc. | 11.03M | -7.37% | 70,574 | - |
| 669 | BLCM | Bellicum Pharmaceuticals, Inc. | 10.94M | 7.63% | 21,955 | 1.50M |
| 670 | CING | Cingulate, Inc. | 10.75M | -3.02% | 11,488 | - |
| 671 | ONCR | Oncorus, Inc. | 10.65M | -4.61% | 113,286 | - |
| 672 | KTRA | Kintara Therapeutics, Inc. | 10.60M | -4.93% | 58,194 | - |
| 673 | VBLT | Vascular Biogenics Ltd. | 10.40M | -17.17% | 6,705,177 | 854.00K |
| 674 | PHGE | BiomX, Inc. | 10.36M | 1.62% | 124,209 | - |
| 675 | PTIX | Protagenic Therapeutics, Inc. | 10.20M | 2.13% | 6,769 | - |
| 676 | CMND | Clearmind Medicine Inc. | 10.13M | 2.35% | 79,325 | - |
| 677 | VRAX | Virax Biolabs Group Limited | 10.01M | -7.58% | 135,262 | 109.82K |
| 678 | RNAZ | TransCode Therapeutics, Inc. | 9.93M | 2.01% | 385,213 | - |
| 679 | CDIO | Cardio Diagnostics Holdings, Inc. | 9.90M | -4.59% | 14,582 | - |
| 680 | JAGX | Jaguar Health, Inc. | 9.48M | 4.21% | 303,100 | 10.78M |
| 681 | BPTS | Biophytis S.A. | 9.44M | -2.55% | 4,198 | - |
| 682 | VRPX | Virpax Pharmaceuticals, Inc. | 9.44M | -0.51% | 34,481 | - |
| 683 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 9.20M | 4.50% | 113,390 | 349.94K |
| 684 | ARTL | Artelo Biosciences, Inc. | 9.14M | -0.31% | 7,641 | - |
| 685 | ELOX | Eloxx Pharmaceuticals, Inc. | 9.06M | -1.88% | 11,968 | - |
| 686 | SILO | Silo Pharma, Inc. | 9.01M | -12.53% | 15,494 | 72.10K |
| 687 | XRTX | XORTX Therapeutics Inc | 8.84M | -11.23% | 915,507 | - |
| 688 | NAVB | Navidea Biopharmaceuticals, Inc. | 8.76M | -3.36% | 85,697 | 115.39K |
| 689 | XBIO | Xenetic Biosciences, Inc. | 8.74M | 1.05% | 57,751 | 1.55M |
| 690 | UNCY | Unicycive Therapeutics, Inc. | 8.45M | -7.05% | 67,968 | - |
| 691 | ADIL | Adial Pharmaceuticals, Inc. | 8.35M | -5.53% | 256,641 | - |
| 692 | SNPX | Synaptogenix, Inc. | 7.99M | 2.80% | 115,869 | - |
| 693 | NBSE | NeuBase Therapeutics, Inc. | 7.90M | -3.44% | 97,388 | - |
| 694 | CELZ | Creative Medical Technology Holdings, Inc. | 7.88M | 3.70% | 137,393 | 137.75K |
| 695 | IBIO | iBio, Inc. | 7.79M | 2.76% | 185,134 | 2.17M |
| 696 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.56M | 2.63% | 102,674 | - |
| 697 | FRTX | Fresh Tracks Therapeutics, Inc. | 7.53M | 0.40% | 22,082 | 5.00M |
| 698 | XTLB | XTL Biopharmaceuticals Ltd. | 7.36M | 7.14% | 211 | - |
| 699 | PHIO | Phio Pharmaceuticals Corp. | 7.10M | -8.78% | 91,100 | - |
| 700 | XCUR | Exicure, Inc. | 6.95M | 0.72% | 11,195 | 9.17M |
| 701 | HILS | Hillstream BioPharma, Inc. | 6.92M | 11.23% | 113,133 | - |
| 702 | HOTH | Hoth Therapeutics, Inc. | 6.91M | -2.44% | 116,616 | - |
| 703 | ATXI | Avenue Therapeutics, Inc. | 6.60M | -10.97% | 1,015,598 | - |
| 704 | REVB | Revelation Biosciences, Inc. | 6.59M | -1.58% | 557,639 | - |
| 705 | KPRX | Kiora Pharmaceuticals, Inc. | 6.41M | -2.72% | 53,107 | - |
| 706 | BNTC | Benitec Biopharma Inc. | 6.40M | -0.48% | 97,676 | 51.77K |
| 707 | TMBR | Timber Pharmaceuticals, Inc. | 6.39M | 1.42% | 48,006 | 273.18K |
| 708 | ONCS | OncoSec Medical Incorporated | 6.39M | -0.46% | 33,504 | - |
| 709 | CWBR | CohBar, Inc. | 6.37M | 5.29% | 18,854 | - |
| 710 | WINT | Windtree Therapeutics, Inc. | 6.33M | -0.18% | 666,501 | - |
| 711 | PTE | PolarityTE, Inc. | 6.02M | 5.02% | 124,437 | 1.86M |
| 712 | ENVB | Enveric Biosciences, Inc. | 5.96M | - | 30,677 | - |
| 713 | VIRI | Virios Therapeutics, Inc. | 5.96M | 3.17% | 240,375 | - |
| 714 | ADTX | Aditx, Inc. | 5.84M | -6.85% | 130,311 | 853.15K |
| 715 | SLRX | Salarius Pharmaceuticals, Inc. | 5.51M | -5.47% | 285,640 | - |
| 716 | VYNT | Vyant Bio, Inc. | 5.45M | 2.50% | 97,680 | -1.91M |
| 717 | FWBI | First Wave BioPharma, Inc. | 5.40M | -4.40% | 425,648 | - |
| 718 | QLGN | Qualigen Therapeutics, Inc. | 5.22M | - | 69,482 | 5.07M |
| 719 | TENX | Tenax Therapeutics, Inc. | 5.13M | 7.69% | 74,421 | - |
| 720 | BVXV | BiondVax Pharmaceuticals Ltd. | 4.92M | -4.40% | 47,219 | - |
| 721 | NBRV | Nabriva Therapeutics PLC | 4.59M | -2.03% | 30,380 | 35.63M |
| 722 | PALI | Palisade Bio, Inc. | 4.52M | 0.90% | 353,044 | - |
| 723 | ENSC | Ensysce Biosciences, Inc. | 4.49M | -9.01% | 2,679,963 | - |
| 724 | HSTO | Histogen, Inc. | 4.36M | -0.97% | 47,812 | 3.77M |
| 725 | NBY | NovaBay Pharmaceuticals, Inc. | 4.30M | 13.37% | 100,762 | 12.14M |
| 726 | NVIV | Invivo Therapeutics Holdings Corp. | 4.21M | -4.35% | 58,885 | - |
| 727 | DRMA | Dermata Therapeutics, Inc. | 4.07M | 17.65% | 880,982 | - |
| 728 | TCBP | TC BioPharm (Holdings) plc | 4.05M | -10.53% | 5,546,761 | 2.41M |
| 729 | VLON | Vallon Pharmaceuticals, Inc. | 3.68M | -3.43% | 213,122 | - |
| 730 | KRBP | Kiromic BioPharma, Inc. | 3.62M | 2.32% | 16,161,007 | - |
| 731 | CYTO | Altamira Therapeutics Ltd. | 3.59M | -14.24% | 173,505 | 1.35M |
| 732 | ALLR | Allarity Therapeutics, Inc. | 3.51M | 4.52% | 3,998,140 | - |
| 733 | SPRC | SciSparc Ltd. | 3.16M | -3.93% | 343,747 | - |
| 734 | CNSP | CNS Pharmaceuticals, Inc. | 3.00M | -6.25% | 21,615 | - |
| 735 | CFRX | ContraFect Corporation | 2.99M | -25.62% | 39,862,256 | - |
| 736 | MTP | Midatech Pharma PLC | 2.88M | -0.26% | 46,286 | 570.73K |
| 737 | INM | InMed Pharmaceuticals, Inc. | 2.86M | -5.76% | 224,651 | 1.41M |
| 738 | CALA | Calithera Biosciences, Inc. | 1.85M | -6.89% | 405,294 | - |
| 739 | PBLA | Panbela Therapeutics, Inc. | 1.68M | -11.18% | 2,377,348 | - |
| 740 | BXRX | Baudax Bio, Inc. | 1.68M | -1.95% | 532,076 | 1.36M |
| 741 | STAB | Statera Biopharma, Inc. | 1.53M | -7.44% | 853,436 | 3.02M |